Harvey Capital Management Inc Cytokinetics Inc Transaction History
Harvey Capital Management Inc
- $422 Million
- Q4 2024
A detailed history of Harvey Capital Management Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Harvey Capital Management Inc holds 22,105 shares of CYTK stock, worth $1.1 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
22,105Holding current value
$1.1 Million% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
125MCall Options Held
4.61MPut Options Held
2.46M-
Black Rock Inc. New York, NY14.7MShares$733 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$588 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$484 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$389 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$323 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.7B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...